Season's Savings | ₹5/mo for 3 months
₹199/month after first 3 months. Renews automatically. Terms apply.
RVMD Today - Aug 08: Exciting Drug Launch Buzz
Failed to add items
Sorry, we are unable to add the item because your shopping basket is already at capacity.
Add to cart failed.
Please try again later
Add to wishlist failed.
Please try again later
Remove from wishlist failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
Written by:
About this listen
So, what happened? RVMD saw a nice bump today, and it’s all about the buzz around their pancreatic cancer drug. People are pretty hyped about it. The company’s getting ready to launch what they’re calling a potential blockbuster. That kind of talk gets investors excited, right?
Now, why the hype? Well, there’s been some chatter about their study data for the drug, and even Martin Shkreli, you know, the controversial figure from the pharma world, stepped in to defend the data. Not everyone loves him, but when he talks about a drug, people listen. Plus, there was news about a 45% surge in another biotech related to pancreatic cancer tests, which probably got the whole sector buzzing. It’s like a wave, and RVMD is riding it!
On the horizon, the company’s gearing up for this launch, and they’re really pumped about it. They’re saying they’re ready to go, which always sounds promising. Launching a drug like this could be a game-changer for them.
So, to wrap it up, RVMD had a good day, fueled by excitement over their pancreatic cancer drug and some lively conversation around their study data. Always a bit of drama in biotech, right? Just remember, this is all for your info and entertainment, not financial advice. Catch you later!
adbl_web_anon_alc_button_suppression_t1
No reviews yet